Glucagon-like peptide-1 receptor agonists for major cardiovascular and kidney outcomes in type 1 diabetes
Individuals with type 1 diabetes (T1D) have higher risks of cardiovascular disease and chronic kidney disease compared with individuals without diabetes1. Despite advances in glycemic management, 31% and 7% of…